Diabetes Care, Vol 23, Issue 1 1-8, Copyright © 2000 by American Diabetes Association

ARTICLES

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes

R Gougeon, K Styhler, JA Morais, PJ Jones and EB Marliss
McGill Nutrition and Food Science Center, Royal Victoria Hospital, Montreal, Quebec, Canada. rgougeon@rvhmed.lan.mcgill.ca

OBJECTIVE: We tested whether oral hypoglycemic agents (OHA), gliclazide with or without metformin, during an isoenergetic (ISO) and then a low-energy diet (LED) improve the altered kinetics of whole-body protein metabolism in type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 13 type 2 diabetic patients (aged 51+/-2 years, weight 110+/-5 kg, BMI 41+/-1 kg/m2, fasting glucose [FSG] 11.5+/-0.9 mmol/l) (means+/-SEM) and 10 obese control subjects (48+/-3 years, 98+/-6 kg, 37+/-2 kg/m2, FSG 5.5+/-0.3 mmol/l) consumed an ISO, 1.5 g x kg(-1) x day(-1) protein for a body weight corresponding to a BMI of 25 (BMI25), a formula diet (7 days for obese control subjects, 15 days for diabetic patients), and then a 28-day LED with 50% of the energy of ISO but the same protein intake (101+/-2 g/day). OHAs were given during ISO (days 8-15) and LED. On days 6-8 (and 12-14 for diabetic subjects) of ISO and 26-28 of LED, the 60-h oral 15N-glycine method was used to obtain nitrogen flux (Q), synthesis (S), and breakdown (B). Muscle protein catabolism was estimated from N(tau)-methylhistidine (3MH) excretion. RESULTS: During ISO with hyperglycemia, Q, and B adjusted for fat-free mass, sex, and age were higher and nitrogen balance and net endogenous protein synthesis (S-B) lower than in control subjects (P<0.05). OHA decreased FSG (9+/-1 mmol/l) and 3MH and increased plasma insulin-to-glucose ratio, nitrogen retention, and S-B to levels in control subjects. The change in S-B correlated with that in FSG (r = -0.845, P = 0.001) and in fasting plasma C-peptide (r = 0.852, P = 0.0005). With LED and OHA, weight decreased 6.3 kg, glycemia reached near-normal levels, and nitrogen equilibrium was maintained; Q decreased by 7%, S and B by 11% (P<0.05) to values found in control subjects. CONCLUSIONS: OHA during ISO corrected protein turnover in relation to glycemia and plasma C-peptide. The LED maintained protein homeostasis in obese control subjects and, in diabetes patients with OHA, normalized protein metabolism. These findings have implications for diet and OHA prescription.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Gougeon, J. A. Morais, S. Chevalier, S. Pereira, M. Lamarche, and E. B. Marliss Determinants of Whole-Body Protein Metabolism in Subjects With and Without Type 2 Diabetes Diabetes Care, January 1, 2008; 31(1): 128 - 133. [Abstract] [Full Text] [PDF]

				S. Pereira, E. B. Marliss, J. A. Morais, S. Chevalier, and R. Gougeon Insulin Resistance of Protein Metabolism in Type 2 Diabetes Diabetes, January 1, 2008; 57(1): 56 - 63. [Abstract] [Full Text] [PDF]

				American Diabetes Association Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association Diabetes Care, January 1, 2008; 31(Supplement_1): S61 - S78. [Full Text] [PDF]

				M. J. Fowler Diabetes Treatment, Part 1: Diet and Exercise Clin. Diabetes, July 1, 2007; 25(3): 105 - 109. [Full Text] [PDF]

				American Diabetes Association Nutrition Recommendations and Interventions for Diabetes-2006: A position statement of the American Diabetes Association. Diabetes Care, September 1, 2006; 29(9): 2140 - 2157. [Full Text] [PDF]

				S. Chevalier, S. C. Burgess, C. R. Malloy, R. Gougeon, E. B. Marliss, and J. A. Morais The Greater Contribution of Gluconeogenesis to Glucose Production in Obesity Is Related to Increased Whole-Body Protein Catabolism Diabetes, March 1, 2006; 55(3): 675 - 681. [Abstract] [Full Text] [PDF]

				M. L. Christensen, B. Meibohm, E. V. Capparelli, P. Velasquez-Mieyer, G. A. Burghen, and W. V. Tamborlane Single- and Multiple-Dose Pharmacokinetics of Pioglitazone in Adolescents With Type 2 Diabetes J. Clin. Pharmacol., October 1, 2005; 45(10): 1137 - 1144. [Abstract] [Full Text] [PDF]

				S. Chevalier, E. B Marliss, J. A Morais, M. Lamarche, and R. Gougeon Whole-body protein anabolic response is resistant to the action of insulin in obese women Am. J. Clinical Nutrition, August 1, 2005; 82(2): 355 - 365. [Abstract] [Full Text] [PDF]

				R. L. Rothman, R. Malone, B. Bryant, C. Wolfe, P. Padgett, D. A. DeWalt, M. Weinberger, and M. Pignone The Spoken Knowledge in Low Literacy in Diabetes Scale: A Diabetes Knowledge Scale for Vulnerable Patients The Diabetes Educator, March 1, 2005; 31(2): 215 - 224. [Abstract] [Full Text] [PDF]

				L. Pedelty and P. B. Gorelick Chronic Management of Blood Pressure After Stroke Hypertension, July 1, 2004; 44(1): 1 - 5. [Full Text] [PDF]

				R. Rothman, R. Malone, B. Bryant, C. Horlen, D. DeWalt, and M. Pignone The Relationship Between Literacy and Glycemic Control in a Diabetes Disease-Management Program The Diabetes Educator, March 1, 2004; 30(2): 263 - 273. [PDF]

				S. M Virtanen and M. Knip Nutritional risk predictors of {beta} cell autoimmunity and type 1 diabetes at a young age Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1053 - 1067. [Abstract] [Full Text] [PDF]

				P. Coon and K. Zulkowski Adherence to American Diabetes Association Standards of Care by Rural Health Care Providers Diabetes Care, December 1, 2002; 25(12): 2224 - 2229. [Abstract] [Full Text] [PDF]

				E. B. Marliss and R. Gougeon Diabetes Mellitus, Lipidus Et... Proteinus! Diabetes Care, August 1, 2002; 25(8): 1474 - 1476. [Full Text] [PDF]

				M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]

				D. Simmons, C. F. Thompson, C. Conroy, and D. J. Scott Use of Insulin Pumps in Pregnancies Complicated by Type 2 Diabetes and Gestational Diabetes in a Multiethnic Community Diabetes Care, December 1, 2001; 24(12): 2078 - 2082. [Abstract] [Full Text] [PDF]